GPCRs-Targeted Drug Discovery Summit Leaderboard
  • Sunday, May 3, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 834

Author

Pharma Journalist 8769 posts 0 comments

Crown Bioscience collaborates with Jiangsu Qyun Bio-Pharmaceutical to develop antibody

May 7, 2017
Crown Bioscience announced collaboration with Jiangsu Qyun Bio-Pharmaceutical to develop antibody. The goal of the collaboration is to develop a less toxic CTLA-4 antibody and better…
Read More...

GenSight appoints Mohamed Genead as CMO

May 6, 2017
GenSight announced that it has appointed Mohamed Genead as Chief medical Officer, effective from May 1, 2017. He will be responsible for setting strategy for and execution of global…
Read More...

AstraZeneca enters a $2.1 billion collaboration with Pieris for drug research

May 6, 2017
AstraZeneca announced that it entered a strategic collaboration worth $2.1 billion with Pieris Pharmaceuticals to develop novel inhaled drugs that leverage Pieris’ Anticalin platform.…
Read More...

Epizyme Earns $10 Million from GSK for GLP Toxicology studies

May 6, 2017
Epizyme has earned a $10 million milestone payment from GlaxoSmithKline (GSK) to follow GSK's initiation of GLP toxicology studies for a first-in-class methyltransferase inhibitor…
Read More...

Corvus Pharmaceutical Expands its Collaboration with Genentech

May 6, 2017
Corvus Pharmaceuticals has expanded its clinical collaboration with Genentech. Under the new agreement, CPI-444 administered in combination with atezolizumab (Tecentriq) will be…
Read More...

Provista appoints Jim Cunniff as new president and CEO

May 6, 2017
Provista appoints Jim Cunniff as new president and CEO who will succeed Dan Thomas. He assumed his new role with Provista on May 1, 2017. Prior to joining Provista, Cunniff was the…
Read More...

Quivive Pharma and Camargo Pharmaceutical Services join hands for Development Programs

May 6, 2017
Quivive has entered into service agreements with Camargo Pharmaceutical Services. Camargo will be providing regulatory consulting and strategic development services for Quivive's…
Read More...

SGS announces completion of Phase I flu trials in healthy Volunteers

May 6, 2017
SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers. The study used a GMP-manufactured, non-hemagglutinating,…
Read More...

Sorrento Announces Completion of GMP Manufacturing Plant in Suzhou

May 6, 2017
Sorrento Therapeutics  announced that Levena has completed construction and put into operation a 25,000 square foot GMP (Good Manufacturing Practice) manufacturing facility in Suzhou,…
Read More...

Alcami Corporation to invest $5 million to expand Charleston County operations

May 5, 2017
Alcami Corporation announced an investment of  $5 million in the expansion of its existing Charleston County operations. Alcami offers a variety of biopharmaceutical services across…
Read More...
Prev Next
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
GPCRs-Targeted Drug Discovery Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Measuring Patient Engagement Summit
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
PFS & Injectable Drug Devices East Coast
5th ADC Analytical Development Summit
Nasal Formulation & Delivery Summit
Peptide-Based Therapeutics Summit 2026
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Gilead Completes $7.8 Billion Arcellx Acquisition Deal
  • EU Approves Rhapsido for Chronic Hives Treatment
  • Lilly to Acquire Ajax in $2.3 Billion Deal
  • Saphnelo Pen Approval Expands Lupus Treatment Access
  • BioMarin Completes $4.8 Billion Amicus Acquisition

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

Targeted LNP Delivery Beyond the Liver: The Challenges…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.